vorinostat has been researched along with Cancer of Mouth in 11 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oral cancer is one of the main causes of cancer-related deaths in South-Asian countries." | 1.42 | Potential Compounds for Oral Cancer Treatment: Resveratrol, Nimbolide, Lovastatin, Bortezomib, Vorinostat, Berberine, Pterostilbene, Deguelin, Andrographolide, and Colchicine. ( Bisen, PS; Bundela, S; Sharma, A, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Akhlaq, R | 1 |
| Khan, T | 1 |
| Ahmed, T | 1 |
| Musharraf, SG | 1 |
| Ali, A | 1 |
| Bundela, S | 1 |
| Sharma, A | 1 |
| Bisen, PS | 1 |
| Jang, B | 1 |
| Shin, JA | 1 |
| Kim, YS | 1 |
| Kim, JY | 1 |
| Yi, HK | 1 |
| Park, IS | 1 |
| Cho, NP | 1 |
| Cho, SD | 1 |
| Nagumo, T | 1 |
| Takaoka, S | 1 |
| Yoshiba, S | 1 |
| Ohashi, M | 1 |
| Shirota, T | 1 |
| Hatori, M | 1 |
| Isobe, T | 1 |
| Tachikawa, T | 1 |
| Shintani, S | 1 |
| Suzuki, M | 3 |
| Endo, M | 1 |
| Shinohara, F | 3 |
| Echigo, S | 3 |
| Rikiishi, H | 3 |
| Yeh, CC | 1 |
| Deng, YT | 1 |
| Sha, DY | 1 |
| Hsiao, M | 1 |
| Kuo, MY | 1 |
| Bai, LY | 1 |
| Chiu, CF | 1 |
| Pan, SL | 1 |
| Sargeant, AM | 1 |
| Shieh, TM | 1 |
| Wang, YC | 1 |
| Weng, JR | 1 |
| Li, J | 1 |
| Gong, C | 1 |
| Feng, X | 1 |
| Zhou, X | 1 |
| Xu, X | 1 |
| Xie, L | 1 |
| Wang, R | 1 |
| Zhang, D | 1 |
| Wang, H | 1 |
| Deng, P | 1 |
| Zhou, M | 1 |
| Ji, N | 1 |
| Zhou, Y | 1 |
| Wang, Y | 1 |
| Wang, Z | 3 |
| Liao, G | 1 |
| Geng, N | 1 |
| Chu, L | 1 |
| Qian, Z | 1 |
| Chen, Q | 2 |
| Sato, T | 1 |
| Sato, Y | 1 |
| Shen, J | 1 |
| Huang, C | 1 |
| Jiang, L | 1 |
| Gao, F | 1 |
| Zhang, Y | 1 |
| Bai, J | 1 |
| Zhou, H | 1 |
| Nishimura, K | 1 |
11 other studies available for vorinostat and Cancer of Mouth
| Article | Year |
|---|---|
PX-12 synergistically enhances the therapeutic efficacy of vorinostat under hypoxic tumor microenvironment in oral squamous cell carcinoma in vitro.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Disulfides; Head and Neck Neoplasms; Histone Deacetylase | 2023 |
Potential Compounds for Oral Cancer Treatment: Resveratrol, Nimbolide, Lovastatin, Bortezomib, Vorinostat, Berberine, Pterostilbene, Deguelin, Andrographolide, and Colchicine.
Topics: Administration, Oral; Algorithms; Antineoplastic Agents; Berberine; Bortezomib; Colchicine; Database | 2015 |
Growth-suppressive effect of suberoylanilide hydroxamic acid (SAHA) on human oral cancer cells.
Topics: Acetylation; Animals; Apoptosis; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Extr | 2016 |
Antitumor activity of suberoylanilide hydroxamic acid against human oral squamous cell carcinoma cell lines in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cyclin-Dependent Kinase Inhibitor p21; Dru | 2009 |
Enhancement of cisplatin cytotoxicity by SAHA involves endoplasmic reticulum stress-mediated apoptosis in oral squamous cell carcinoma cells.
Topics: Apoptosis; Carcinoma, Squamous Cell; Caspase 12; Caspase Inhibitors; Caspases, Initiator; Cell Line, | 2009 |
Suberoylanilide hydroxamic acid sensitizes human oral cancer cells to TRAIL-induced apoptosis through increase DR5 expression.
Topics: Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Drug Synergism | 2009 |
Antitumor activity of a novel histone deacetylase inhibitor (S)-HDAC42 in oral squamous cell carcinoma.
Topics: Animals; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cyclin D1; Cyclin-Dependent Kinase 6 | 2011 |
Biodegradable thermosensitive hydrogel for SAHA and DDP delivery: therapeutic effects on oral squamous cell carcinoma xenografts.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Cell L | 2012 |
Chemosensitization of oral squamous cell carcinoma cells to cisplatin by histone deacetylase inhibitor, suberoylanilide hydroxamic acid.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Caspases; Cell Cycle; Cell Line, Tumor; | 2007 |
Enhancement of cisplatin induced apoptosis by suberoylanilide hydroxamic acid in human oral squamous cell carcinoma cell lines.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Cel | 2007 |
Epigenetic regulation of chemosensitivity to 5-fluorouracil and cisplatin by zebularine in oral squamous cell carcinoma.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cisplatin; | 2007 |